5-(3-methyl-1-triazeno)imidazole-4-carboxamide and Thrombocytopenia

5-(3-methyl-1-triazeno)imidazole-4-carboxamide has been researched along with Thrombocytopenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baker, SD; Batra, VK; Cutler, DL; Donehower, RC; Rudek, MA; Statkevich, P	1

Trials

1 trial(s) available for 5-(3-methyl-1-triazeno)imidazole-4-carboxamide and Thrombocytopenia

Article	Year
Temozolomide in patients with advanced cancer: phase I and pharmacokinetic study. Pharmacotherapy, 2004, Volume: 24, Issue:1 Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Alkylating Agents; Area Under Curve; Bilirubin; Capsules; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Half-Life; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Temozolomide; Thrombocytopenia; Tissue Distribution; Treatment Failure	2004

Article

Year

Temozolomide in patients with advanced cancer: phase I and pharmacokinetic study.

Pharmacotherapy, 2004, Volume: 24, Issue:1

Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Alkylating Agents; Area Under Curve; Bilirubin; Capsules; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Half-Life; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Temozolomide; Thrombocytopenia; Tissue Distribution; Treatment Failure

2004